摘要:
FIG. 1 is a front elevation view of a smartwatch case showing the new design; FIG. 2 is a back elevation view thereof; FIG. 3 is a left-side view thereof; FIG. 4 is a right-side view thereof; FIG. 5 is a top plan view thereof; FIG. 6 is a bottom plan view thereof; FIG. 7 is a perspective view thereof; and, FIG. 8 is another perspective view thereof. The broken lines depict portions of the smartwatch case and form no part of the claimed design.
摘要:
A method of forming an array of nanostructures includes forming a plurality of seed points on a surface of a substrate, and growing masks from the seed points to create masked regions of the substrate underlying the masks. A remainder of the substrate comprises an unmasked region. Each mask and masked region increase in size with growth time while the unmasked region of the substrate decreases in size. During the growing, the unmasked region is etched to remove material from the substrate in a depth direction, and, simultaneously, unetched structures are formed from the masked regions of the substrate underlying the masks. Each of the unetched structures has a lateral size that increases with depth.
摘要:
Provided are a camptothecin compound containing 7-membered lactone ring, as shown in general formula I, and pharmaceutically acceptable salt thereof, as well as the preparation method and use thereof. In general formula I, R1 is H, a C1˜C3 alkyl, acetyl or propionyl; R2 is H, a C1˜C6 alkyl, a C3˜C6 cycloalkyl, piperidyl; or a C1˜C6 alkyl substituted by an amino; R3 is H, a C1˜C3 alkyl, or a C1˜C6 alkyl substituted by an amino; R4 is H, a hydroxyl, or a C1˜C6 alkoxy; R5 is H, or a C1˜C6 alkoxyl; or R4 and R5 are linked to each other to form —OCH2O— or —OCH2CH2O—. The compound has good anti-tumor activity, and can be clinically used via oral administration, intravenous injection, and intramuscular injection, among others.
摘要:
The present invention is directed to pharmaceutical compositions comprising: (a) a cyclopolysaccharide and (b) a compound of Formula (I) or its pharmaceutical acceptable salt: wherein X1, X2, Q, Z, and m are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compositions.
摘要:
The disclosure includes hydroxamic compounds of Formula I: (Formula I) wherein Z, L, R1, R2, and R3 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
摘要:
A method to operate game of chance using a map of sites as playing surface with moving pieces called movers. There are ruled movements. A random draw of ruled movements move movers from sites to sites. Players bet on own selected movers moving to own selected sits by one or several draws of movements. The holder of a hanging bet earns credit to place free make-up bets. Calculation of the hanging or winning probability of every bet together with its hanging credit or winning payoff will be provided. An automatic computer/video version of the game is included.
摘要:
Substituted bicyclic heteroaryls having the following formula where the variables are as defined herein, and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110□ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
摘要翻译:具有下式的取代的双环杂芳基,其中变量如本文所定义,以及含有它们的组合物,用于治疗一般炎症,关节炎,风湿性疾病,骨关节炎,炎性肠病,炎症性眼病,炎性或不稳定性膀胱病,牛皮癣, 包括但不限于自身免疫性疾病如系统性红斑狼疮(SLE),重症肌无力,类风湿关节炎,急性播散性脑脊髓炎,特发性血小板减少性紫癜,多发性硬化症,Sjoegren综合征和自身免疫性溶血性贫血, 包括所有形式的超敏反应的过敏症状本发明还使得能够治疗依赖于p110□活性或与p110□活性相关的癌症的方法,包括但不限于白血病,例如急性骨髓性白血病(AML)Myelo-dysplastic sy (MDS)骨髓增生性疾病(MPD)慢性骨髓性白血病(CML)T细胞急性淋巴细胞性白血病(T-ALL)B细胞急性淋巴细胞性白血病(B-ALL)非霍奇金淋巴瘤(NHL)B细胞淋巴瘤和 实体肿瘤,如乳腺癌。
摘要:
A method and device for storing and reading/writing a composite document are disclosed. The method includes: an initial storing area is pre-allocated for an inner controlling stream of the composite document and the initial storing area is continuous sectors or sector clusters; the inner controlling stream is stored in the initial storing area. The patches of a user data stream and the inner controlling stream in the composite document are reduced using the method or device. Correspondingly, pre-allocating storing area makes the probability of continuously storing the user data stream and the inner controlling stream in the composite document increased. The I/O can be optimized by introducing a strategy of reading cache and writing in a batch size, which can improve the efficiency of reading and writing.